NICOLE HENDERSON-COLE: Open Payments
NPI 1073795688 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 18 payments from 8 companies in 2025. Trend: 2023 $727 · 2024 $713 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Vanda Pharmaceuticals Inc. | 3 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Almatica Pharma LLC | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: CAPLYTA, REXULTI, FANAPT, TRINTELLIX, LOREEV XR, Auvelity, Qelbree, COBENFY.
Industry payments across NJ — which companies pay providers there.
